METTL3 regulated m6A modification, and IGF2BP3 recognized the 3’UTR region of EMP1 mRNA, which could be eliminated by silencing METTL3 in pancreatic cancer cells (Fig. 3G). Here, IGF2BP3 is linked to pancreatic neoplasm.